Giant axonal neuropathy: studies with sulfhydryl donor compounds

Rup Tandan, Walter G Bradley, Michael J. Fillyaw

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Giant axonal neuropathy (GAN) is a disorder characterized pathologically by distal neurofilament-filled bulbous swellings in axons, and widespread collection of intermediate filaments, including masses of vimentin filaments in cultured skin fibroblasts. A morphologically similar neurofibrillary disorder is produced by acrylamide and the toxic hexacarbons, agents which bind to thiol groups. We report, in GAN fibroblasts, inhibition of vimentin filament aggregation by dithiothreitol and penicillamine, sulfhydryl donor compounds which stabilize thiols. In addition, we describe clinical improvement in a GAN patient treated with penicillamine, despite earlier progressive disease. These findings support the hypothesis of disordered thiol metabolism in GAN, and open up avenues for further research.

Original languageEnglish
Pages (from-to)153-162
Number of pages10
JournalJournal of the Neurological Sciences
Volume95
Issue number2
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Giant Axonal Neuropathy
Sulfhydryl Compounds
Tissue Donors
Penicillamine
Intermediate Filaments
Vimentin
Fibroblasts
Acrylamide
Dithiothreitol
Poisons
Axons
Skin
Research

Keywords

  • Dithiothreitol
  • Fibroblasts
  • Giant axonal neuropathy
  • Glutathione
  • Penicillamine
  • Vimentin filaments

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Neuroscience(all)
  • Developmental Neuroscience
  • Neurology

Cite this

Giant axonal neuropathy : studies with sulfhydryl donor compounds. / Tandan, Rup; Bradley, Walter G; Fillyaw, Michael J.

In: Journal of the Neurological Sciences, Vol. 95, No. 2, 01.01.1990, p. 153-162.

Research output: Contribution to journalArticle

@article{4258bb79a18644909a532a8aea6508fb,
title = "Giant axonal neuropathy: studies with sulfhydryl donor compounds",
abstract = "Giant axonal neuropathy (GAN) is a disorder characterized pathologically by distal neurofilament-filled bulbous swellings in axons, and widespread collection of intermediate filaments, including masses of vimentin filaments in cultured skin fibroblasts. A morphologically similar neurofibrillary disorder is produced by acrylamide and the toxic hexacarbons, agents which bind to thiol groups. We report, in GAN fibroblasts, inhibition of vimentin filament aggregation by dithiothreitol and penicillamine, sulfhydryl donor compounds which stabilize thiols. In addition, we describe clinical improvement in a GAN patient treated with penicillamine, despite earlier progressive disease. These findings support the hypothesis of disordered thiol metabolism in GAN, and open up avenues for further research.",
keywords = "Dithiothreitol, Fibroblasts, Giant axonal neuropathy, Glutathione, Penicillamine, Vimentin filaments",
author = "Rup Tandan and Bradley, {Walter G} and Fillyaw, {Michael J.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/0022-510X(90)90238-I",
language = "English",
volume = "95",
pages = "153--162",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Giant axonal neuropathy

T2 - studies with sulfhydryl donor compounds

AU - Tandan, Rup

AU - Bradley, Walter G

AU - Fillyaw, Michael J.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Giant axonal neuropathy (GAN) is a disorder characterized pathologically by distal neurofilament-filled bulbous swellings in axons, and widespread collection of intermediate filaments, including masses of vimentin filaments in cultured skin fibroblasts. A morphologically similar neurofibrillary disorder is produced by acrylamide and the toxic hexacarbons, agents which bind to thiol groups. We report, in GAN fibroblasts, inhibition of vimentin filament aggregation by dithiothreitol and penicillamine, sulfhydryl donor compounds which stabilize thiols. In addition, we describe clinical improvement in a GAN patient treated with penicillamine, despite earlier progressive disease. These findings support the hypothesis of disordered thiol metabolism in GAN, and open up avenues for further research.

AB - Giant axonal neuropathy (GAN) is a disorder characterized pathologically by distal neurofilament-filled bulbous swellings in axons, and widespread collection of intermediate filaments, including masses of vimentin filaments in cultured skin fibroblasts. A morphologically similar neurofibrillary disorder is produced by acrylamide and the toxic hexacarbons, agents which bind to thiol groups. We report, in GAN fibroblasts, inhibition of vimentin filament aggregation by dithiothreitol and penicillamine, sulfhydryl donor compounds which stabilize thiols. In addition, we describe clinical improvement in a GAN patient treated with penicillamine, despite earlier progressive disease. These findings support the hypothesis of disordered thiol metabolism in GAN, and open up avenues for further research.

KW - Dithiothreitol

KW - Fibroblasts

KW - Giant axonal neuropathy

KW - Glutathione

KW - Penicillamine

KW - Vimentin filaments

UR - http://www.scopus.com/inward/record.url?scp=0025105117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025105117&partnerID=8YFLogxK

U2 - 10.1016/0022-510X(90)90238-I

DO - 10.1016/0022-510X(90)90238-I

M3 - Article

C2 - 2324766

AN - SCOPUS:0025105117

VL - 95

SP - 153

EP - 162

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -